{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:23:34Z","timestamp":1777083814054,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002345","name":"University of T\u00fcbingen","doi-asserted-by":"crossref","award":["IZKF-1686-0-0"],"award-info":[{"award-number":["IZKF-1686-0-0"]}],"id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","award":["DKH-111708"],"award-info":[{"award-number":["DKH-111708"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander Foundation","doi-asserted-by":"crossref","award":["2015.016.1"],"award-info":[{"award-number":["2015.016.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejca.2017.12.002","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T05:42:49Z","timestamp":1515217369000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival"],"prefix":"10.1016","volume":"91","author":[{"given":"Anja","family":"Ulmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Werner-Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Martin","family":"H\u00e4fner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Breuninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Fierlbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejca.2017.12.002_bib1","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.12.002_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1245\/s10434-012-2701-z","article-title":"Diversity of stage III melanoma in the era of sentinel lymph node biopsy","volume":"20","author":"Egger","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2017.12.002_bib3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2017.12.002_bib4","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1245\/s10434-009-0665-4","article-title":"Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma","volume":"16","author":"Ghaferi","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2017.12.002_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ejca.2014.02.010","article-title":"Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy","volume":"50","author":"Khosrotehrani","year":"2014","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2017.12.002_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2013.3044","article-title":"Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system","volume":"148","author":"Leung","year":"2013","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.ejca.2017.12.002_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2013.50.7681","article-title":"Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study","volume":"32","author":"Pasquali","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.12.002_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2009.11.695","article-title":"Sentinel lymph node biopsy and melanoma: 2010 update Part I","volume":"62","author":"Stebbins","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"36","key":"10.1016\/j.ejca.2017.12.002_bib9","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.12.002_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/DAD.0b013e31829432c7","article-title":"Histopathologic evaluation of the sentinel lymph node for malignant melanoma: the unstandardized process","volume":"36","author":"Cole","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"10.1016\/j.ejca.2017.12.002_bib11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1245\/s10434-015-4625-x","article-title":"Identification, clinical significance, and management of very small melanoma metastases in sentinel lymph nodes","volume":"22","author":"Cochran","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2017.12.002_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jcp.52.12.871","article-title":"Histopathological workup of sentinel lymph nodes: how much is enough?","volume":"52","author":"van Diest","year":"1999","journal-title":"J Clin Pathol"},{"issue":"19","key":"10.1016\/j.ejca.2017.12.002_bib13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2017.12.002_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.12.002_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejca.2011.08.019","article-title":"Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study","volume":"48","author":"Riber-Hansen","year":"2012","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2017.12.002_bib16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/cncr.24268","article-title":"Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap","volume":"115","author":"Riber-Hansen","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.12.002_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejca.2017.09.014","article-title":"The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients","volume":"86","author":"Eggermont","year":"2017","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.ejca.2017.12.002_bib18","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1158\/1078-0432.CCR-04-1995","article-title":"Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes","volume":"11","author":"Ulmer","year":"2005","journal-title":"Clin Canc Res"},{"issue":"2","key":"10.1016\/j.ejca.2017.12.002_bib19","doi-asserted-by":"crossref","first-page":"e1001604","DOI":"10.1371\/journal.pmed.1001604","article-title":"Quantitative measurement of melanoma spread in sentinel lymph nodes and survival","volume":"11","author":"Ulmer","year":"2014","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.ejca.2017.12.002_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejca.2017.12.002_bib21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejso.2013.07.006","article-title":"Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes","volume":"39","author":"Murali","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.12.002_bib22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.2010.33.1884","article-title":"Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis","volume":"29","author":"Valsecchi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.12.002_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejso.2012.10.014","article-title":"Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients","volume":"39","author":"Wevers","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2017.12.002_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.09.002","article-title":"Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria","volume":"87","author":"Madu","year":"2017","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2017.12.002_bib25","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","article-title":"Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria","volume":"29","author":"van der Ploeg","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2017.12.002_bib26","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1245\/s10434-015-4615-z","article-title":"Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases","volume":"22","author":"Holtkamp","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2017.12.002_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ejca.2017.12.002_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","article-title":"The orderly progression of melanoma nodal metastases","volume":"220","author":"Reintgen","year":"1994","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejca.2017.12.002_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.12.002_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917314582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T17:26:42Z","timestamp":1535131602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917314582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"alternative-id":["S0959804917314582"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.12.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}